Senseonics/$SENS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Senseonics

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Ticker

$SENS

Primary listing

AMEX

Industry

Health Care Equipment & Supplies

Employees

117

ISIN

US81727U1051

Senseonics Metrics

BasicAdvanced
$413M
-
-$0.11
1.06
-

What the Analysts think about Senseonics

Analyst ratings (Buy, Hold, Sell) for Senseonics stock.

Bulls say / Bears say

Senseonics received FDA approval for its Eversense 365 Continuous Glucose Monitoring (CGM) system and launched it in partnership with Ascensia, leading to a 56% increase in its global patient base in 2024. (stockhouse.com)
H.C. Wainwright raised its price target for Senseonics to $1.40, citing growth drivers such as the expected approval and launch of Eversense 365 in the EU and integration with Sequel Diabetes' twiist insulin delivery system. (investing.com)
Senseonics anticipates doubling its global patient base in 2025, projecting revenues between $34 million and $38 million, driven by the rollout of Eversense 365 to U.S. patients. (drugdeliverybusiness.com)
Senseonics reported a net loss of $15.5 million in Q4 2024, indicating ongoing financial challenges despite revenue growth. (drugdeliverybusiness.com)
The company announced a $50 million public offering of common stock, which could lead to shareholder dilution. (tradingview.com)
BTIG maintained a Neutral rating on Senseonics shares, expressing caution despite FDA clearance for the Eversense 365 CGM system. (investing.com)
Data summarised monthly by Lightyear AI. Last updated on 11 Jul 2025.

Senseonics Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Senseonics Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SENS

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs